Back to Search
Viorele
by Glenmark Pharmaceuticals Inc., USAContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.02Mg,0.01Mg

Progestin

Desogestrel

0.15Mg

Regimen Protocol

Biphasic Shortened hormone-free interval (28-day cycle with <7 placebo days)

Androgenicity

Low/Reduced Androgenic

Approval Date

4/2/2012

Additives
None
Inactive Ingredients
lactosetitanium dioxidevitamin Epotato starchpovidoneisopropyl alcoholcolloidal silicon dioxidestearic acidhypromellosemacrogoltalcstarchmagnesium stearateiron oxide yellowFD&C blue No. 2 indigo carmine aluminum lake

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Mayne Pharma Inc.

Azurette

Lupin Ltd

Bekyree

Naari Pte Ltd

Desogestrel And Ethinyl Estradiol

Xiromed Llc

Desogestrel And Ethinyl Estradiol

Teva Pharmaceuticals USA, Inc.

Kariva

Northstar Rx LLC

Pimtrea

Aurobindo Pharma Limited

Simliya

Xiromed, LLC.

Volnea

Have clinical questions about Viorele?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy